You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 196 No. 13, June 27, 1966 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

The Diagnosis of Pheochromocytoma

Analysis of 26 Cases

Edward L. Moorhead II, MD; John R. Caldwell, MD; Annetta R. Kelly, PhD; Azorides R. Morales, MD

JAMA. 1966;196(13):1107-1113.


Abstract

Twenty-six cases of pheochromocytoma were seen in a 14-year period (1951-1964) at the Henry Ford Hospital. The presenting complaint often seemed unrelated to the presence of pheochromocytoma. Only 13 patients (50%) gave a history of hypertension, and six were normotensive at the time of initial examination. In 14 of the 18 patients who complained of paroxysmal attacks, the diagnosis was made preoperatively or antemortem. In contrast, the diagnosis was not established clinically in the eight patients failing to report paroxysms. This would seem to point to the importance of ruling out pheochromocytoma in those thought to have primary or socalled essential hypertension. Because of the difficulty of excluding pheochromocytoma by means of clinical examination, it is recommended that ideally either a histamine or phentolamine test be done on every patient with newly diagnosed hypertension.



Author Affiliations

From Medical Division No. 6 (Dr. Moorhead), the Division of Hypertension (Dr. Caldwell), and the Department of Laboratories (Drs. Kelly and Morales), Henry Ford Hospital, Detroit. Dr. Moorhead is an American Cancer Society fellow in oncology.


Footnotes

Reprint requests to 2799 W Grand Blvd, Detroit 48202 (Dr. Moorhead).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Uncommon Presentation of Pheochromocytoma: Case Studies
Grossman et al.
ANGIOLOGY 1985;36:759-765.
ABSTRACT  

Plasma Norepinephrine Response to Standing in Patients With Pheochromocytoma or Medullary Carcinoma of the Thyroid
Feldman et al.
Arch Intern Med 1979;139:81-85.
ABSTRACT  

Sipple's Syndrome: Medullary Thyroid Carcinoma, Pheochromocytoma, and Parathyroid Disease: Studies in a Large Family
KEISER et al.
ANN INTERN MED 1973;78:561-579.
ABSTRACT  

Familial Pheochromocytoma: Association With Von Hippel-Lindau's Disease
Sharp and Platt
ANGIOLOGY 1971;22:141-146.
 





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1966 American Medical Association. All Rights Reserved.